WordNet

make a map of; show or establish the features of details of; "map the surface of Venus"
to establish a mapping (of mathematical elements or sets) (同)represent
a diagrammatic representation of the earths surface (or part of it)
plan, delineate, or arrange in detail; "map ones future" (同)map out
depict as if on a map; "sorrow was mapped on the mothers face"
explore or survey for the purpose of making a map; "We havent even begun to map the many galaxies that we know exist"
locate within a specific region of a chromosome in relation to known DNA or gene sequences; "map the genes"
the 13th letter of the Roman alphabet (同)m
an enzyme that catalyzes the conversion of a proenzyme to an active enzyme

PrepTutorEJDIC

(1枚1枚の)『地図』;天体図 / …‘の'地図を作る;…‘を'地図にかく
Mach number / mark[s] / Monsieur
Massachusetts / mental age

Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2012/04/09 17:20:07」(JST)

wiki en

The mitogen-activated protein kinase (MAPK) pathway.^[1]^[2]^[3]^[4]^[5]^[6]^[7]^[8]^[9]^[10]

Mitogen-activated protein (MAP) kinases (EC 2.7.11.24) are serine/threonine-specific protein kinases that respond to extracellular stimuli (mitogens, osmotic stress, heat shock and proinflammatory cytokines) and modulates cellular activities, such as proliferation, gene expression, differentiation, mitosis, cell survival, and apoptosis.^[11]

Overview of signal transduction pathways involved in apoptosis.

Activation

MAP kinases are activated within the protein kinase cascades called “MAPK cascade”. Each one consists of three enzymes, MAP kinase kinase kinase (MKKK, MEKK or MAP3K), MAP kinase kinase (MKK, MEK, or MAP2K) and MAP kinase that are activated in series. A MAP3K that is activated by extracellular stimuli phosphorylates a MAP2K on its serine and threonine residues, and this MAP2K activates a MAP kinase through phosphorylation on its threonine and tyrosine residues (Tyr-185 and Thr-183 of ERK2). In vivo and in vitro, phosphorylation of tyrosine precedes phosphorylation of threonine, although phosphorylation of either residue can occur in the absence of the other. Because both tyrosine and threonine phosphorylations are required to activate the MAP kinases, phosphatases that remove phosphate from either site will inactivate them.

The MAP kinase signaling cascades convey information to effectors, coordinate incoming information from other signaling pathways, amplify signals, and allow for a variety of response patterns. They respond to different stimuli by phosphorylating cytoplasmic components and nuclear transcription factors depending on the cellular context. Down-regulation of MAP kinase pathways may occur through dephosphorylation by serine/threonine phosphatases, tyrosine phosphatases, or dual-specificity phosphatases and through feedback inhibitory mechanisms that involve the phosphorylation of upstream kinases. Drugs that selectively down-regulate MAP kinase cascades could prove to be valuable as therapeutic agents in the control of malignant disease.

Groups

ERK1 and ERK2 were the first of the ERK/MAP kinase subfamily to be cloned. Other related mammalian enzymes have been detected including: two ERK3 isoforms, ERK4, Jun N-terminal kinases/stress-activated protein kinases (JNK/SAPKs), p38/HOG, and p57 MAP kinases (38). The presence of at least six MAP kinases in yeast suggests that there are more in mammals.

extracellular signal-regulated kinases (ERK1, ERK2). The ERK1/2 (also known as classical MAP kinases) signaling pathway is preferentially activated in response to growth factors and phorbol ester (a tumor promoter), and regulates cell proliferation and cell differentiation.
c-Jun N-terminal kinases (JNKs), (MAPK8, MAPK9, MAPK10) also known as stress-activated protein kinases (SAPKs).
p38 isoforms.(p38-α (MAPK14), -β (MAPK11), -γ (MAPK12 or ERK6) and -δ (MAPK13 or SAPK4)) Both JNK and p38 signaling pathways are responsive to stress stimuli, such as cytokines, ultraviolet irradiation, heat shock, and osmotic shock, and are involved in cell differentiation and apoptosis.
ERK5. ERK5 (MAPK7), which has been found recently, is activated both by growth factors and by stress stimuli, and it participates in cell proliferation.
ERK3/4. ERK3 (MAPK6) and ERK4 (MAPK4) are structurally-related atypical MAPKs possessing SEG motifs in the activation loop and displaying major differences only in the C-terminal extension. ERK3 and ERK4 are primarily cytoplasmic proteins that bind, translocate, and activate MK5 (PRAK, MAPKAP5). ERK3 is unstable, unlike ERK4, which is relatively stable.^[12]
ERK7/8. (MAPK15) This is the newest member of MAPKs and behaves like atypical MAPKs. It possesses a long C terminus similar to ERK3/4.

Control of the MAP kinase cascade

Receptor tyrosine kinase

Various ligands that activate MAPK’s cascade bind receptor tyrosine kinases, and tyrosine residues are phosphorylated; the phosphotyrosine residues of autophosphorylated receptors then bind the SH2 domains of adapters, (Grb2: growth factor receptor-bound protein 2). Exchange factors promote the association of Ras with GTP. GTP-Ras bind Raf-1 and B-Raf, two protein kinases. Consequently, Raf protein kinase activity is increased. Receptor tyrosine kinases have also been reported to activate the cascade in fibroblasts via a [Ca²⁺] increase.

G Protein-coupled receptors

The MAP kinase cascade can also be activated by certain heterotrimeric G proteins.

Protein kinase C

Protein kinase C (PKC) is used by many receptors to regulate the MAP kinase pathway, alone or in concert with other mechanisms, and may act at several steps in the cascade. PKC may directly activate Raf-1, but if a mutation exists at the site phosphorylated by PKC, no interaction can occur with Raf. Other sites of action of PKC are likely to be either farther upstream or at the level of MAP kinase inactivation.

Regulation and specificity of MEKs

MEK1 and MEK2 phosphorylate and activate MAP kinase. MEKs are activated by Raf-1, B-Raf, the Mos protooncogene product, MEK kinase 1 (MEKK1), and other growth factor-stimulated activities. The mechanisms controlling MEKK1 are unknown, although Ras may be required. It is thought MEKs are kinases that phosphorylate only MAP Kinases because no other substrates have been identified.

3D Structure of MAPK1

The MAPK1 structure consists of a smaller N-terminal domain and a larger C-terminal domain connected by a linker.

If MAPK1 is unphosphorylated its activity is very low. Phosphorylation causes both global and local conformational changes.^[13] The two domains of ERK2 are rotated 17° to cause closure of the active site and form the catalytic residues. When Tyr-185 is phosphorylated binds Arg in positions -189 and −192. These new unions may help to stabilize the conformation in the active structure.

MAP kinase mutants and structural implications

Different biochemical and structural studies using mutations of the phosphorylation sites show how phosphorylation increases ERK2 activitiy. An example is that if the mutation is located in Tyr-185, it causes conformational changes that affect ERK2 activation and, so, the activity is lower. It is suggested that cells cannot tolerate the continuous activity of MAP kinase. Constitutively active mutants of MEK transform cells and generate tumors in nude mice. However, effects of activated MEKs could be compensated increasing phosphatase activity to inactivate MAP kinases.

References

^ Rossomando AJ, Payne DM, Weber MJ, Sturgill TW (1989). "Evidence that pp42, a major tyrosine kinase target protein, is a mitogen-activated serine/threonine protein kinase". Proc Natl Acad Sci USA 86 (18): 6940–3. doi:10.1073/pnas.86.18.6940. PMC 297966. PMID 2550926. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=297966.
^ Bonni A, Brunet A, West AE, Datta SR, Takasu MA, Greenberg ME (1999). "Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms". Science 286 (5443): 1358–62. doi:10.1126/science.286.5443.1358. PMID 10558990.
^ Chadee DN, Yuasa T, Kyriakis JM (2002). "Direct Activation of Mitogen-Activated Protein Kinase Kinase Kinase MEKK1 by the Ste20p Homologue GCK and the Adapter Protein TRAF2". Mol. Cell. Biol. 22 (3): 737–49. doi:10.1128/MCB.22.3.737-749.2002. PMC 133545. PMID 11784851. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=133545.
^ Chang L, Karin M (2001). "Mammalian MAP kinase signaling cascades". Nature 410 (6824): 37–40. doi:10.1038/35065000. PMID 11242034.
^ Chen YR, Tan TH (2000). "The c-Jun N-terminal kinase pathway and apoptotic signaling (review)". Int. J. Oncol. 16 (4): 651–62. PMID 10717232.
^ Hazzalin CA, Mahadevan LC (2002). "MAPK-regulated transcription: a continuously variable gene switch?". Nat. Rev. Mol. Cell Biol. 3 (1): 30–40. doi:10.1038/nrm715. PMID 11823796.
^ Kato Y, Kravchenko VV, Tapping RI, Han J, Ulevitch RJ, Lee JD (1997). "BMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C". EMBO J. 16 (23): 7054–66. doi:10.1093/emboj/16.23.7054. PMC 1170308. PMID 9384584. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=1170308.
^ Kiefer F, Tibbles LA, Anafi M, Janssen A, Zanke BW, Lassam N, Pawson T, Woodgett JR, Iscove NN (1996). "HPK1, a hematopoietic protein kinase activating the SAPK/JNK pathway". EMBO J. 15 (24): 7013–25. PMC 452527. PMID 9003777. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=452527.
^ Pearson G, English JM, White MA, Cobb MH (2001). "ERK5 and ERK2 cooperate to regulate NF-kappaB and cell transformation". J. Biol. Chem. 276 (11): 7927–31. doi:10.1074/jbc.M009764200. PMID 11118448.
^ Weston CR, Lambright DG, Davis RJ (2002). "Signal transduction. MAP kinase signaling specificity". Science 296 (5577): 2345–7. doi:10.1126/science.1073344. PMID 12089430.
^ Pearson G, Robinson F, Beers Gibson T, Xu BE, Karandikar M, Berman K, Cobb MH (2001). "Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions". Endocr. Rev. 22 (2): 153–83. doi:10.1210/er.22.2.153. PMID 11294822.
^ Kant S, Schumacher S, Singh MK, Kispert A, Kotlyarov A, Gaestel M. (2006). "Characterization of the atypical MAPK ERK4 and its activation of the MAPK-activated protein kinase MK5". J Biol Chem. 281 (46): 35511–9. doi:10.1074/jbc.M606693200. PMID 16973613.
^ Canagarajah, Bertram; Khokhlatchev A, Cobb MH, Goldsmith EJ (5). "Activation mechanism of the MAP kinase ERK2 by dual phosphorylation". Cell 90 (5): 859–69. doi:10.1016/S0092-8674(00)80351-7. PMID 9298898.

External links

MAP Kinase Resource .
Table of names for mitogen-activated kinases.
MAPK cascade picture
MeSH Mitogen-Activated+Protein+Kinases
Model of MAPK ultrasensitivity in BioModels Database
Drosophila rolled - The Interactive Fly

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 黒色腫（メラノーマ）の分子生物学 the molecular biology of melanoma
2. Toll様受容体：疾患および治療における役割 toll like receptors roles in disease and therapy
3. 転移性黒色腫（メラノーマ）の分子標的療法 molecularly targeted therapy for metastatic melanoma
4. リウマチ性疾患におけるサイトカインネットワーク：治療の意味 cytokine networks in rheumatic diseases implications for therapy
5. 進行皮膚黒色腫に対するマネージメントの概要 overview of the management of advanced cutaneous melanoma

English Journal

PP2A blockade inhibits autophagy and causes intraneuronal accumulation of ubiquitinated proteins.

Magnaudeix A, Wilson CM, Page G, Bauvy C, Codogno P, Lévêque P, Labrousse F, Corre-Delage M, Yardin C, Terro F.SourceLaboratoire d'Histologie, de Biologie Cellulaire et de Cytogénétique, Faculté de Médecine, Université de Limoges, Limoges, France.
Neurobiology of aging.Neurobiol Aging.2013 Mar;34(3):770-90. doi: 10.1016/j.neurobiolaging.2012.06.026. Epub 2012 Aug 11.
Using cultured cortical neurons, we show that the blockade of protein phosphatase 2A (PP2A), either pharmacologically by okadaic acid or by short hairpin RNA (shRNA)-mediated silencing of PP2A catalytic subunit, inhibited basal autophagy and autophagy induced in several experimental settings (includ
PMID 22892312

Fluoro-Sorafenib (Regorafenib) effects on hepatoma cells: Growth inhibition, quiescence, and recovery.

Carr BI, Cavallini A, Lippolis C, D'Alessandro R, Messa C, Refolo MG, Tafaro A.SourceLaboratory of Biochemistry, National Institute for Digestive Diseases, IRCCS "Saverio de Bellis," Castellana Grotte (BA), Italy. brianicarr@hotmail.com.
Journal of cellular physiology.J Cell Physiol.2013 Feb;228(2):292-7. doi: 10.1002/jcp.24148.
To evaluate the growth-inhibitory properties of the potent multi-kinase antagonist Regorafenib (Fluoro-Sorafenib), which was synthesized as a more potent Sorafenib, a Raf inhibitor and to determine whether similar mechanisms were involved, human hepatoma cell lines were grown in the presence or abse
PMID 22777740

Japanese Journal

Processive phosphorylation of ERK MAP kinase in mammalian cells.

Aoki Kazuhiro,Yamada Masashi,Kunida Katsuyuki,Yasuda Shuhei,Matsuda Michiyuki
Proceedings of the National Academy of Sciences of the United States of America, 2011-07-18
… 2011-07-19.The mitogen-activated protein (MAP) kinase pathway is comprised of a three-tiered kinase cascade. … The distributive kinetic mechanism of two-site MAP kinase phosphorylation inherently generates a nonlinear switch-like response. … However, a linear graded response of MAP kinase has also been observed in mammalian cells, and its molecular mechanism remains unclear. …
NAID 120003204017

High-dose tobramycin inhibits lipopolysaccharide-induced MUC5AC production in human lung epithelial cells.

Nakamura Shigeki,Yanagihara Katsunori,Araki Nobuko,Yamada Koichi,Morinaga Yoshitomo,Izumikawa Koichi,Seki Masafumi,Kakeya Hiroshi,Yamamoto Yoshihiro,Kamihira Shimeru,Kohno Shigeru
European journal of pharmacology 659(1), 67-71, 2011-05-20
… Tobramycin suppressed the phosphorylation of extracellular signal-regulated protein kinase, p38 MAP kinase. … These results suggest that high-dose tobramycin, such as inhalation therapy, can inhibit MUC5AC gene expression and MUC5AC protein production in NCI-H292 cells, in part through the mitogen-activated protein kinase pathway. …
NAID 120003220709

Related Pictures

★リンクテーブル★

リンク元	「抗原受容体」「MAPキナーゼ」「shc」
拡張検索	「MAP kinase kinase 1」「MAP kinase kinase kinase 2」「MAP kinase kinase kinase 5」「MAP kinase kinase kinase」
関連記事	「map」「MAP」「MA」「kinase」「M」

「抗原受容体」

Mitogen-activated protein kinase
Identifiers
EC number	2.7.11.24
CAS number	142243-02-5
Databases
IntEnz	IntEnz view
BRENDA	BRENDA entry
ExPASy	NiceZyme view
KEGG	KEGG entry
MetaCyc	metabolic pathway
PRIAM	profile
PDB structures	RCSB PDB PDBe PDBsum
Gene Ontology	AmiGO / EGO
Search
PMC	articles
PubMed	articles

　　[★]

抗原受容体

TCR(T細胞受容体)
BCR(抗体)

シグナル伝達

	T細胞	B細胞
抗原受容体	TCR(β鎖, α鎖)	BCR(H鎖, L鎖)
受容体に付随するタンパク質	CD3δ	Igα
	CD3ε	Igβ
	CD3γ
	ζ
	CD5	CD19
	CD6	CD22
Src kinase	Lck, Fyn	Kyn, Blk, Fyn
Syc kinase ZAP-70 kinase	ZAP-70,Syk	Syk
Down stream enzymes	MAP kinase
	Vav
	PLCγ1	PLCγ1, PLCγ2
	GAP(+/-)	GAP
		PI3 kinase
Others	Ezrin
Others	Valosin-containing protein